NuScale Power Corporation Faces Securities Fraud Lawsuit Following 12% Stock Decrease

NuScale Power Corporation, a significant player in the nuclear technology industry, is facing a lawsuit for securities fraud. The lawsuit alleges that the company, along with some senior executives, deceived investors by failing to disclose key information about their partnership with ENTRA1 Energy LLC. Initial claims made by NuScale implied that ENTRA1 had extensive experience in constructing power production facilities. However, it was later revealed that ENTRA1 had no significant background in the development and operation of power plants, especially in the intricate field of nuclear energy generation.

The stock value of NuScale took a hit following these revelations. In the third quarter of 2025, NuScale’s general and administrative expenses soared from $17 million to $519 million due to a payment of $495 million made to ENTRA1 for their services. NuScale’s acknowledgment that ENTRA1 lacked any substantial experience in building nuclear power projects, coupled with the assertion that they would not be directly involved in constructing power plants, led to a plunge in NuScale’s stock value by $4.03 per share, representing a decrease of more than 12.4%.

Analysts from Guggenheim Securities, LLC pointed out that ENTRA1 was essentially a three-year-old entity with minimal operational background and was mainly structured to support Wadie Habboush, an investor and entrepreneur. This exposure of ENTRA1’s limited scope and involvement played a significant role in the stock price decline experienced by NuScale. The negative revelations about ENTRA1’s capabilities and the subsequent impact on NuScale’s stock value are key factors addressed in the ongoing class-action lawsuit against NuScale.

Investors who have suffered losses due to the drop in NuScale’s stock value following the ENTRA1 controversy are encouraged to explore their legal options. The class-action lawsuit is pending in the U.S. District Court for the District of Oregon, with a deadline of April 20, 2026, for investors to seek leadership roles in the case. Shareholders affected by the events involving NuScale and ENTRA1 are advised to submit their information to the law firm, Bleichmar Fonti & Auld LLP, for further guidance on potential legal remedies.

Bleichmar Fonti & Auld LLP is an esteemed law firm specializing in securities class actions and shareholder litigation. Acknowledged for its successful representation of plaintiffs in similar cases, including notable victories against Tesla, Inc. and Teva Pharmaceutical Ind. Ltd., the firm offers legal services on a contingency fee basis, ensuring that shareholders do not bear any upfront costs. By providing comprehensive legal assistance and seeking court approval for related fees and expenses, Bleichmar Fonti & Auld LLP aims to support affected investors in seeking justice and potential recovery in the NuScale case.